1. Introduction and background {#sec0005}
==============================

The eye is divided into the anterior and posterior segments ([Fig. 1](#fig0005){ref-type="fig"}a) [@bib0005]. Prominent anterior segment structures include the cornea, iris, pupil, crystalline lens, and ciliary body. Prominent posterior segment structures include the vitreous body, retina, choroid, and optic nerve. All of these structures work together in a coordinated manner to provide visual information to the brain. However, before visual information is sent to the brain, it undergoes processing by structures in both the anterior and posterior segments. First, the cornea and lens form images on the retina [@bib0010], while the iris simultaneously adjusts pupil size to control the amount of light that reaches the retina. Second, retinal photoreceptors convert light into electrical signals [@bib0005], while pigment in the retinal pigment epithelium (RPE, mainly containing melanin) absorbs unnecessary light [@bib0015]. Third, retinal neurons modulate electrical signals and send them to brain for further processing.

Retinal and RPE processing of visual information consumes large amount of energy and oxygen [@bib0020]. Two delicate vascular circulation systems, the retinal and choroidal circulations, collectively support the retina ([Fig. 1](#fig0005){ref-type="fig"}b) [@bib0025]. In a healthy eye, the retinal circulation mainly delivers oxygen and nutrients to the inner retinal tissues and the choroidal circulation mainly nourishes photoreceptors [@bib0030].

Eye diseases compromise, and even disable, normal functions of ocular components, which can threaten vision. Studies have demonstrated that variations in retinal blood oxygen saturation (sO~2~) and RPE melanin concentration play an important role in several prevalent blinding ocular diseases. The sO~2~ has been shown to be abnormal in diabetic retinopathy (DR) [@bib0035], [@bib0040], [@bib0045], glaucoma [@bib0050], [@bib0055], and retinal venous occlusion [@bib0060], [@bib0065]. Additionally, RPE melanin loss and lipofuscin accumulation have been shown to contribute to the progression of age-related macular degeneration (AMD) [@bib0070], [@bib0075], [@bib0080]. The ability to precisely detect aberrant retinal sO~2~ values and RPE melanin concentrations can be important for improving investigations and diagnoses of ocular diseases.

In the past decades, large efforts have been made to quantitatively measure sO~2~ and melanin concentration in the eye. Multi-wavelength fundus photography has been tested for a long time to measure retinal sO~2~ [@bib0085], [@bib0090], [@bib0095] and has the advantage of being a non-contact technique. However, multi-wavelength fundus photographs often provide inaccurate measurements because of light scattering within retinal tissues and the RPE pigmentations [@bib0100]. Invasive methods, including fluorescence life-time imaging and oxygen-sensitive microelectrode measurements, have been used to measure the partial pressure of oxygen in retinal tissue [@bib0105], [@bib0110], but these methods are only suitable for laboratorial animal studies. Visible-light optical coherence tomography (vis-OCT) was recently used to successfully quantify retinal and choroidal sO~2~ in rodents [@bib0115], [@bib0120], [@bib0125]. This non-contact technique has the benefits of accurately measuring sO~2~ [@bib0130] and providing images with high depth resolution [@bib0115]. Therefore, vis-OCT has the potential to provide retinal and choroidal sO~2~ measurements in the clinical setting. However, measurements made with vis-OCT have not yet been verified at many other different anatomical sites. This must be done before vis-OCT is tested in the clinical setting.

Measurements of RPE melanin have mostly been obtained during *in vitro* experiments. The most direct method to calculate melanin concentration involves manually counting melanin granules on high-magnification micrographs [@bib0135]. A less direct *in vitro* method involves measuring optical absorption of solubilized free melanin granules [@bib0140], [@bib0145]. However, the invasive nature of these *in vitro* techniques prevents them from being used in clinical settings. Instead, spectroscopic fundus photography and near-infrared autofluorescence (NIR-AF) imaging are used to measure RPE melanin concentration *in vivo* [@bib0150], [@bib0155], [@bib0160]. Spectroscopic fundus photography uses mathematical optical models to estimate melanin optical density. However, over-simplified optical models used in spectral fundus photography calculations result in inaccurate melanin concentration measurements. The NIR-AF technique measures melanin concentration using the coincidence between the strong AF and NIR-excited melanin emission signals [@bib0160]. Unfortunately, a rigorous model that describes the relationship between AF and melanin has not yet been developed. Therefore, better non-invasive methods to measure retinal/choroidal blood sO~2~ and RPE melanin concentration are still needed.

Blood and melanin both have high optical absorption coefficients within the visible light spectral range ([Fig. 2](#fig0010){ref-type="fig"}) and optical absorption can be used to measure their concentrations [@bib0165]. Photoacoustic (PA) imaging has been shown to precisely and non-invasively measure optical absorption properties [@bib0170], [@bib0175], [@bib0180], [@bib0185], [@bib0190], [@bib0195], [@bib0200], and have already been used to measure both blood sO~2~ and melanin concentration in the ear [@bib0205], [@bib0210], [@bib0215], [@bib0220], brain [@bib0225], [@bib0230], esophagus [@bib0235], [@bib0240], colon [@bib0235], [@bib0240], and epidermis (melanin only) [@bib0245], [@bib0250]. Therefore, PA imaging can potentially quantify retinal and choroidal sO~2~ and the RPE melanin. In this mini review, we explain the principle of PA imaging, describe ocular imaging requirements, show PA images of the anterior and posterior ocular segments, and suggest areas of future research that will help bring PA imaging towards clinical ophthalmic applications.

2. Principles of photoacoustic imaging and requirements for imaging the eye {#sec0010}
===========================================================================

2.1. Principles of photoacoustic imaging {#sec0015}
----------------------------------------

The principle of PA imaging has been previously described in other comprehensive reviews [@bib0170], [@bib0175]; only the most essential steps are briefly described here. First, a laser is used to illuminate and excite the material being imaged. Short laser pulse illumination that satisfies both thermal and stress confinements is usually used to enhance the signal-to-noise ratio (SNR) of PA images [@bib0255]. Second, the sample being imaged absorbs some of the delivered laser energy, resulting in heat generation, transient thermoelastic expansion, and ultrasonic signal production. Third, the detected ultrasonic signals are used for both anatomical PA image reconstruction and functional analysis. For image reconstruction, single point laser excitation generates acoustic wave, which is recorded as a function of time. The time resolved PA signal is converted into one-dimensional depth-resolved image, referred to as A-line, based on the sound speed in tissue. A transverse linear scan of the point laser illumination on the sample yields a two-dimensional image by aligning A-lines according to theirs spatial locations, and a two-dimensional raster scan of the point illumination produces a three-dimensional image. For quantifications, the amplitude of the detected ultrasonic wave is proportional to the combination of molar extinction coefficient, the local optical-absorbing chromophore concentration, the local optical fluence, and the ultrasonic transducer response [@bib0260]. Chromophore concentration is generally the variable of interest and can be measured using PA images excited by multiple wavelengths (spectroscopic PA imaging), optical fluence modelling, and numerical analysis [@bib0175].

2.2. Ocular imaging requirements {#sec0020}
--------------------------------

The eye has several unique properties. It is a fragile organ and the photoreceptors are extremely sensitive to light that enters the eye [@bib0265]. The eye is always in motion [@bib0270] and the cornea and crystalline lens have their own optical powers, affecting how light is focused on the retina. Because of these properties, ocular imaging systems must meet several requirements. First, illumination intensity must be within safety limits. Over exposure can damage retina from three possible mechanisms, including thermal damage, thermoacoustic damage, and photochemical damage [@bib0275], [@bib0280]. Different standards, such as International Commission on Non-Ionizing Radiation Protection (ICNIRP) broadband guidelines [@bib0285] and American National Standard for safe use of lasers (ANSI) [@bib0290], are available for guiding ophthalmic imaging safety. Among these different standards, recommended exposure limits are not substantially different. Almost all the reported PA ophthalmic imaging work evaluated their laser safeties according to the ANSI's criteria. Considering the combined effects of wavelength, exposure duration, repetition rate, illumination spot size, and pupil size and so on, ANSI determines ocular laser safety thresholds using the limits of maximum permissible exposure (MPE) for three types of illuminations: single pulse illumination (MPEsp), multiple pluses illumination (MPE~MP~), and average power illumination (MPE~GROUP~). The smallest value among MPE~SP~, MPE~MP~, and MPE~GROUP~ will be the safety limit. Detailed calculation of MPE~SP~, MPE~MP~, and MPE~GROUP~ can be found in ANSI. Second, noninvasive and noncontact imaging is highly preferred by both patients and physicians. Invasive imaging techniques carry the risk of numerous side effects, including, patient discomfort and nausea (from intravenous contrast agent). Third, high-speed imaging is preferred because the eye is always moving [@bib0295] and saccadic eye movements can cause motion artifacts, image blurring, and image distortion.

2.3. Measurements of optical absorption in the eye {#sec0025}
--------------------------------------------------

Because of its high imaging resolution and non-invasiveness, optical absorption sensing attracts increasing attention in measuring RPE melanin concentration and retinal sO~2~. The accuracy, however, depends on how to detect optical absorption, through either indirect or direct measurement. Indirect measurements acquire the fundus reflectance, and inversely calculate optical absorption within retinal blood and melanin based on numerical models such as Lambert-Beer's Law [@bib0300], [@bib0305] or Radiative Transport Theory [@bib0310]. These numerical solutions, however, are sensitive to light scattering and local ocular geometrical parameters, such as retinal thickness, vessel diameters, and retinal pigmentation, thus may result in biased estimations. Taking retinal sO~2~ quantification as an example, optical density (OD) needs to be estimated first as a measure of optical absorption. OD is defined as:$$OD = \log_{10}(\frac{I_{b}}{I_{v}}),$$where *I~b~* is the reflection intensity from the vessel neighboring area, indicating the background reflectance; *I~v~* is the reflection intensity directly from the vessel. In an ideal situation when photon path length within a vessel equals to the vessel diameter *D*, and the influences are negligible from light scattering in blood as well as photon absorption by melanin in *I~v~*. Eq. [(1)](#eq0005){ref-type="disp-formula"} can be rewritten as (details can be found in [@bib0100])$$\begin{array}{l}
{OD = \log_{10}(\frac{I_{b}}{I_{v}})} \\
{= \log_{10}(e^{(\varepsilon_{HbO_{2}}(\lambda) \times \lbrack HbO_{2}\rbrack + \varepsilon_{HbR}(\lambda) \times \lbrack HbR\rbrack) \times D}) + \log_{10}(e^{- \varepsilon_{m}(\lambda) \times C_{m}^{RPE} \times l})} \\
{= \frac{(\varepsilon_{HbO_{2}}(\lambda) \times \lbrack HbO_{2}\rbrack + \varepsilon_{HbR}(\lambda) \times \lbrack HbR\rbrack) \times D}{\ln(10)} - \frac{\varepsilon_{m}(\lambda) \times C_{m}^{RPE} \times l}{\ln(10)}} \\
\end{array},$$where $\varepsilon_{HbO_{2}}(\lambda)$ and $\varepsilon_{HbO}(\lambda)$ are the molar extinction coefficients of oxygenated and deoxygenated hemoglobin; \[*HbR*\] and \[*HbO~2~*\] are concentrations of the deoxygenated and oxygenated hemoglobin; *l* is the optical path length in the RPE; $C_{m}^{RPE}$is the melanin concentration in the RPE; $\varepsilon_{m}(\lambda)$ is the molar extinction coefficient of melanin at wavelength *λ*. From Eq. [(2)](#eq0010){ref-type="disp-formula"}, the OD is underestimated because of the melanin in RPE, which in turn biases sO~2~. In practice, the indirect measurement is, unfortunately, much more complex than the ideal case presented here. For example, the light scattering is strong within the vessel and the photon path length within the vessel will not be equal to vessel diameter *D*, which will further complicate optical absorption retrieve, and misestimate sO~2~.

Compared with indirect measurement, directly measuring optical absorption with PA is more straightforward and can be more accurate. In PA imaging that satisfies requirements of thermal and stress confinements, the thermal expansion caused pressure rise *P~0~* is [@bib0170]$$p_{0} = \Gamma \times \mu_{a} \times F,$$where $\Gamma$ is $Gr\overset{¨}{u}neisen$ coefficient; $\mu_{a}$ is the absorption coefficient; and *F* is the local optical fluence. Taking blood sO~2~ imaging for example, the detected PA amplitude $\text{pa}(x,y,z,\lambda)$ is considered to be proportional to the local optical energy deposition $\phi(x,y,z,\lambda)$, which is a product of local absorption coefficient $\mu_{a}(x,y,z,\lambda)$ and local optical fluence $F(x,y,z,\lambda)$.$$\text{pa}(\lambda,x,y,z) = K_{1} \times \phi(\lambda,x,y,z) = K_{1} \times F(x,y,z,\lambda) \times (\varepsilon_{HbR}(\lambda) \times \lbrack HbR\rbrack + \varepsilon_{HbO_{2}}(\lambda) \times \lbrack HbO_{2}\rbrack),$$where *K*~1~ is the proportionality coefficient, reflecting the system sensitivity and $Gr\overset{¨}{u}neisen$ coefficient. If we consider $F(x,y,z,\lambda)$ a constant, we can simplify $K_{1} \times F(x,y,z,\lambda)$ as *K*~2~. For multiple wavelength PA measurements, Eq. [(4)](#eq0020){ref-type="disp-formula"} becomes$$\text{PA} = K_{2} \times M \times H,$$where $M = \left\lbrack {\begin{matrix}
{\varepsilon_{HbR}(\lambda_{1})} \\
 \vdots \\
{\varepsilon_{HbR}(\lambda_{n})} \\
\end{matrix}\begin{matrix}
{\varepsilon_{HbO_{2}}(\lambda_{1})} \\
 \vdots \\
{\varepsilon_{HbO_{2}}(\lambda_{n})} \\
\end{matrix}} \right\rbrack$, $H = \begin{bmatrix}
{\lbrack HbR\rbrack} \\
{\lbrack HbO_{2}\rbrack} \\
\end{bmatrix}$, and $\text{PA}(x,y,z) = \begin{bmatrix}
{\text{pa}(\lambda_{1},x,y,z)} \\
 \vdots \\
{\text{pa}(\lambda_{n},x,y,z)} \\
\end{bmatrix}$

The sO~2~ value of each vessel was then given by

$sO_{2}(x,y,z) = \frac{{\lbrack HbO_{2}\rbrack}_{(x,y,z)}}{{\lbrack HbO_{2}\rbrack}_{(x,y,z)} + {\lbrack HbR\rbrack}_{(x,y,z)}},$(6)

3. Photoacoustic imaging of the eye {#sec0030}
===================================

Several groups developed PA imaging systems for the eye and reported ocular imaging since 2010 [@bib0315], [@bib0320], [@bib0325]. These ocular PA imaging systems can be classified into different categories. In terms of spatial resolution, there are acoustic-resolution and optical-resolution systems. Acoustic-resolution system weakly focuses excitation light onto ocular tissue, and the focus of the ultrasonic detector determines the imaging resolution [@bib0330], [@bib0335]. Optical-resolution system tightly focuses the excitation light onto ocular tissue, where the optical focal spot determines the resolution [@bib0340]. PA imaging systems can also be categorized into mechanical-scanning and optical-scanning imaging systems. Mechanical-scanning PA imaging usually translates both the optical illumination and ultrasonic detection simultaneously for volumetric imaging [@bib0340]; while optical-scanning system employs a pair of galvanometers to scan a focused optical illumination and maintains the ultrasonic detection stationary [@bib0325], [@bib0345].

Ocular PA imaging of both the anterior and posterior segments has been reported. In the early stages of development, researchers primarily used PA imaging to qualitatively examine ocular structures [@bib0315], [@bib0325], including the iris and retinal vasculature. As PA imaging technology has advanced, more quantitative imaging has been the focus. This includes measurement of sO~2~ [@bib0350] and retinal oxygen metabolic rate (rMRO~2~) [@bib0355]. In this section, we summarize the development of ocular PA imaging of both anterior and posterior segment structures of the eye.

3.1. Anterior eye segment imaging {#sec0035}
---------------------------------

The major contrast of anterior segment PA imaging come from the red blood cells in the iris microvasculature and iris melanin. To image iris microvasculature and melanin, illumination light is directly focused on the iris. Both acoustic and optical resolution images were reported, but only a mechanical scanning system was used. de la Zerda et al. [@bib0315] qualitatively assessed the rabbit eye using acoustic resolution PA microscopy (AR-PAM). They successfully detected PA signals from the iris, but the iris microvasculature was not clearly visible in AR-PAM images because of the limited lateral resolution (approximately 200 μm). Mechanical-scanning optical resolution PA microscopy (OR-PAM) was used by Hu et al. [@bib0320] to obtain high resolution *in vivo* images of the iris microvascular in an albino mouse. [Fig. 3](#fig0015){ref-type="fig"}a shows the OR-PAM system, in which a microscope objective lens (numerical aperture NA = 0.46) tightly focuses laser illumination light onto the iris microvasculature to achieve a lateral resolution of approximately 5 μm. Hu et al. [@bib0320] placed a water tank on top of the eye to relay ultrasonic signals from the iris to a focused 75 MHz ultrasonic detector ([Fig. 3](#fig0015){ref-type="fig"}a). [Fig. 3](#fig0015){ref-type="fig"}b shows the clearly visible iris microvasculature, where the diameter of a single capillary was estimated to be 6 μm. By using two excitation wavelengths (570 nm and 578 nm) with different oxy-hemoglobin and deoxy-hemoglobin absorption coefficients, Hu et al. [@bib0320] also quantitatively measured sO~2~ of the iris microvasculature, as shown by the false-color map of the vasculature in [Fig. 3](#fig0015){ref-type="fig"}b.

Iris melanin has also been measured using PA imaging. In an *ex vivo* pig eye experiment, Ronald et al. [@bib0360] used a mechanical scanning PA imaging system to image the iris melanin using both 1064-nm and 532-nm wavelength illuminations. An image obtained using the 532-nm light is shown in [Fig. 3](#fig0015){ref-type="fig"}c. The authors observed strong PA signals from iris melanin with a 532 nm excitation light because melanin has a much larger absorption coefficient at 532 nm than it does at 1064 nm. Liu et al. [@bib0365] obtained *in vivo* images of mouse iris melanin using a mechanical-scanning OR-PAM system at an excitation wavelength of 532 nm. However, these melanin PA imaging studies only examined qualitative measures and, to date, quantitative measurements of iris melanin have not been obtained.

Imaging of anterior segment pathology with PAM has also been performed in *ex vivo* experiments and on wild-type rodents. Liu et al. [@bib0365] used a mechanical scanning OR-PAM to image corneal neovascularization in mice with alkali burns. In that study, a low-power objective lens (NA = 0.1) focused excitation light (523 nm) onto the cornea to image the abnormal vasculature. Laser-induced ultrasonic signals were relayed to a focused ultrasonic detector (10 MHz) *via* a water tank that had been set on top of the cornea. [Fig. 4](#fig0020){ref-type="fig"}a shows an *en face* projection PA imaging of the anterior eye segment, with signals from the cornea and iris being stacked together. [Fig. 4](#fig0020){ref-type="fig"}b shows a PAM B-scan image of corneal vasculature and iris melanin. After segmentation of the cornea vasculature from iris melanin, a clear corneal vascular map was obtained ([Fig. 4](#fig0020){ref-type="fig"}c).

Nearly all anterior segment PA images have been obtained with a mechanical scanning OR-PAM. However, there are concerns regarding mechanical-scanning OR-PAM imaging systems. First, mechanical scanning OR-PAM has a very limited imaging speed, where obtaining a 2 mm × 2 mm image can take more than 30 min [@bib0320]. Second, a water tank, usually placed on top of the eye, is needed to achieve ultrasonic coupling between the eye and the ultrasonic detector [@bib0320], [@bib0365]. Therefore, these systems are not suitable for clinics, which requires fast imaging speeds and improved ultrasonic detection (as further discussed in Sections [3.2](#sec0040){ref-type="sec"} and [4](#sec0045){ref-type="sec"}).

3.2. Posterior segment imaging {#sec0040}
------------------------------

Posterior segment PA imaging of a normal eye images melanin in the RPE and red blood cells in the retinal and choroidal microvasculature. Both AR-PAM and OR-PAM systems have been used to obtain posterior segment images, along with mechanical scanning and optical scanning systems. de la Zerda et al. [@bib0315] demonstrated AR-PAM imaging of the retina and choroid in an *ex vivo* pig eye. Unfortunately, lateral image resolution was too low (around 200 μm) to visualize any features of the retinal or choroidal vasculature. To improve lateral resolution, Wu et al. [@bib0370] used OR-PAM imaging, which has a resolution of approximately 5 μm, to image the posterior segment in mice eyes. Although improved images of the retinal vasculature were obtained, the mechanical scanning caused a few concerns. First, as stated in Section [3.1](#sec0035){ref-type="sec"}, mechanical scanning PAM usually has low imaging speed and requires ultrasonic coupling between the eye and the ultrasonic transducer with a water tank. Additionally, for mechanical scanning OR-PAM imaging, laser-induced ultrasonic signals from the posterior segment must pass through the crystalline lens before reaching the ultrasonic transducer. Unfortunately, the lens strongly attenuates ultrasonic signals [@bib0375], which severely reduces the SNR of PA images. In experiments performed by Wu et al. [@bib0370] in mice, clear visualization of retinal vascular features was only achieved with an intense excitation laser power, which was above the ocular laser safety limit.

Jiao et al. [@bib0325] developed an optical-scanning PAM system, referred to as a photoacoustic ophthalmoscope (PAOM), to better image posterior segment [@bib0325], [@bib0345]. In their PAOM system ([Fig. 5](#fig0025){ref-type="fig"}a), a 532-nm pulse laser was used as the illumination source (pulse duration: 2 ns; pulse repetition rate: 30 kHz), with output pulse laser light coupled to a 1 × 2 single-mode optical fiber. One output was used for compensating for laser intensity variation; the other was the excitation source, which was steered by a pair of galvanometer mirrors and relayed to the cornea by a pair of telescope lenses [@bib0325]. Laser-induced PA waves from the posterior segment were detected by a custom-built needle ultrasonic transducer (center wavelength: 30 MHz; bandwidth: 50%; active element diameter: 1 mm), which was placed in contact with the eyelid and coupled by ultrasound gel ([Fig. 5](#fig0025){ref-type="fig"}b). The lateral and axial resolution of PA images was approximately 20 and 23 μm, respectively. PAOM has several advantages over mechanical-scanning OR-PAM. First, PAOM's imaging speed (up to 30 kHz) is much faster than that of any mechanical-scanning OR-PAM. Second, there is no need to place a water tank on top of the eye to achieve ultrasonic coupling. Instead, an ultrasonic needle transducer is directly coupled to the eyelid. Third, the needle transducer in PAOM detects most ultrasonic signals propagating from vitreous humor to eyelid, which prevents strong ultrasonic signals attenuation from lens and enables high SNR imaging. Several studies have successfully used PAOM to obtain high quality images of the retinal vasculature, the choroidal vasculature, and RPE melanin in rodents ([Fig. 6](#fig0030){ref-type="fig"}) [@bib0345], [@bib0380], [@bib0385], [@bib0390], [@bib0395], [@bib0400], [@bib0405].

Multi-modal imaging can be very beneficial for investigating ocular pathological and detecting disease [@bib0410], [@bib0415]. For the readers' convenience, we briefly summarize merits and concerns of different ophthalmic imaging devices in [Table 1](#tbl0005){ref-type="table"}, including OCT, confocal scanning laser ophthalmoscopy (cSLO), fundus photography, hyperspectral imaging (HSI), and PAOM.

When PAOM is integrated with other imaging modalities, more structural and functional information can be obtained. For example, integrating PAOM and auto-florescence imaging can provide information on the retinal vasculature and on the distribution and concentration of retinal melanin and lipofuscin [@bib0380]. Combining multi-wavelength PAOM and fluorescein angiography [@bib0345] can measure retinal blood sO~2~ and map the retinal and choroidal vasculature. The most useful integrated imaging system utilizes both multi-wavelength PAOM and OCT ([Fig. 5](#fig0025){ref-type="fig"}a), which has several advantages. OCT can provide both structural and functional information of the posterior segment. With broadband illumination, OCT can detail 3D retinal and choroidal structural information with high axial and lateral resolutions [@bib0420], [@bib0425]. Using repeated scanning, OCT can achieve complete retinal vasculature mapping [@bib0430], [@bib0435], [@bib0440]. By detecting Doppler phase shifts caused by moving blood, OCT can quantitatively measure retinal blood velocity and flow rate [@bib0445], [@bib0450], [@bib0455]. Implementation of polarization sensitive OCT [@bib0460], [@bib0465], [@bib0470], retinal birefringence can be retrieved. Besides aforementioned advantages, OCT can also guide PAOM imaging, allowing PAOM to image a specific region of interest in the posterior segment [@bib0475]. Multi-wavelength PAOM can quantify retinal sO~2~ and has the potential to measure RPE melanin concentration [@bib0480]. Recently, Wei and Liu et al. [@bib0355], [@bib0485] successfully measured rMRO~2~ in rats using an integrated PAOM and OCT system. Retinal sO~2~ was calculated using PAOM measurements at three wavelengths (570 nm, 578 nm, and 588 nm; [Fig. 7](#fig0035){ref-type="fig"}b), and blood flow rate was quantified by the near infrared Doppler OCT (NIR-OCT) (center wavelength: 850 nm; bandwidth: 50 nm; [Fig. 7](#fig0035){ref-type="fig"}e). For our readers' convenience, we summarize the reported ocular PA imaging systems in [Table 2](#tbl0010){ref-type="table"}.

4. Future studies to bring photoacoustic imaging to the clinical setting {#sec0045}
========================================================================

This section focuses on investigations that can potentially facilitate the beginning clinical trials with PA ocular imaging systems.

4.1. Technique development {#sec0050}
--------------------------

### 4.1.1. Non-contact detection of photoacoustic signals {#sec0055}

As already stated in Section 3.1, a major concern about current ocular PA imaging systems is the requirement of physical contact between the eye and the ultrasonic detector. In reported works, researchers either placed a water tank above the cornea or directly coupled an ultrasonic needle transducer with the eyelid using ultrasonic gel [@bib0355]. However, these methods are not ideal for the clinical settings. Detection methods that require contact with the eye generally cause patient discomfort. Additionally, physical motion from eye saccades and head movements can affect coupling between ultrasonic transducer and eyeball, and influence PA image SNR. Lastly, current ultrasonic coupling methods are not ideal. When a water tank is used for ultrasonic coupling, integration of PA and other imaging modalities becomes difficult. When using direct coupling between a needle detector and the eyelid, a long working distance is required. This forces the objective to have a very small NA for PA imaging systems and other integrated imaging modalities like OCT.

Novel detection methods are needed to overcome these issues and many are already under investigation. Some researchers have studied wearable, transparent ultrasonic detectors that can be fitted to clinical ocular PA imaging devices. Zhang group [@bib0490], [@bib0495], [@bib0500] developed a small-footprint, optically transparent, micro-ring resonator to detect ultrasonic signals (diameter of a few millimetres). The micro-ring resonator has a lower noise equivalent pressure [@bib0490] than other ultrasonic detectors. These properties make it feasible for this transducer to be fabricated into a contact lens, which can serve as an ultrasonic detector for ocular PA imaging. Even though the contact lens is still a contact detector, it does not require ultrasonic gel for coupling and allows for a flexible working distance, which will reduce patient discomfort as well as facilitate integration of PA imaging with other imaging modalities.

Other non-contact ultrasonic detectors have been also extensively studied. Several groups used interferometer to sense surface displacement induced by laser excitation [@bib0505], [@bib0510], [@bib0515], [@bib0520], [@bib0525] in preliminary experiments. Sampathkumar and Silverman [@bib0530] used a Michelson interferometer to detect PA signals in *ex vivo* porcine eyes. Chen et al. [@bib0535] used an OCT to detect *in vivo* PA signals in a mouse ear. Rousseau et al. [@bib0520] detected PA signals using a Fabry-Perot interferometer on a chicken breast tissue sample. Unfortunately, concerns about all reported non-contact ultrasonic detection methods include performance stability and detection sensitivity [@bib0490]. Future studies are needed so that better non-contact PA methods can be discovered.

### 4.1.2. Development of innovative laser sources for photoacoustic ophthalmic imaging {#sec0060}

Suitable laser sources of PAOM will need to have a short pulse duration (for example, 10 ns or shorter), sufficient pulse energy (for example, 40 nJ) and high repetition rate. Qualified eye anatomical images are achievable with monochromatic pulse laser illumination. Liu et al. [@bib0365] employed a single wavelength Nd:YAG pulse laser (532 nm wavelength, 1 ns pulse duration, 80 nJ pulse energy, and 1 kHz pulse repetition rate) to image corneal neovascularization structures. Zerda et al. [@bib0315] applied Na:YAG laser combined with an optical parametric oscillator (OPO) modulator (740 nm wavelength, 5 ns pulse duration, 0.5 mJ/cm^2^ fluence rate) to image the whole eye structures. Using PAOM to resolve ocular functional information requires multi-wavelength laser illuminations. Hu et al. [@bib0320] used a tunable pulse dye laser at two wavelengths (570 nm and 578 nm) to measure iris vascular sO~2~; Song et al. [@bib0355] also recruited a tunable pulse dye laser at three wavelengths (578 nm, 580 nm, 588 nm) to quantify retinal sO~2~. To access multimodal information, PAOM is usually integrated with other imaging modalities, for instance, OCT. The integrated PAOM and OCT, however, require different types of illuminations, and thus demand separate light sources [@bib0355], which is inconvenient. A single laser source that allows both PA imaging and OCT was recently investigated. With phantom experiments, Lee et al. [@bib0540] shown that a near-infrared supercontinuum laser can allow both PA and OCT imaging. Recently, Liu et al. [@bib0545] successfully acquired *in vivo* rat retinal images from simultaneous PAOM and OCT by using a single ultrafast laser source (center wavelength 800 nm, bandwidth 30 nm, pulse duration 3 ns, repetition rate 10 kHz). To further develop a compact and cost-effective PA imaging system, researchers have also developed pulse laser diodes (PLDs) as alternative laser excitation sources [@bib0550], [@bib0555], and mouse ear vascular structures were successfully obtained. Ophthalmic applications of PLDs are not reported yet and are still under investigation.

### 4.1.3. Imaging depth, resolution and speed of photoacoustic ophthalmoscopy {#sec0065}

An optimal PAOM system requires the extended imaging depth to cover both retina and choroid, high lateral and axial resolutions to resolve RPE melanin, and fast imaging speed to circumvent motion artifacts. For imaging depth, application of optical clearing agents can reduce tissue scattering influences and allow deep imaging [@bib0560], which, however, is not suitable for *in vivo* ocular using. Near-infrared light (NIR) PAM can image much deeper than visible light [@bib0565], the required high power excitation in NIR is a potential safety concern. Besides, sO~2~ measurement may be difficult with NIR illumination. The lateral imaging resolution of PAOM is limited to around 20 μm in rodent eyes, which is not enough to resolve retinal capillaries. The low lateral resolutions of PAOM result from a narrow laser beam used, which aims to reduce influence of aberration from ocular lens. To improve the lateral resolution, the synthetic-aperture technique can potentially be implemented in PAOM [@bib0570], [@bib0575]. The axial resolution of PAOM is determined by the bandwidth of the ultrasonic transducer and larger ultrasonic bandwidth will allow higher axial resolution. However, a transducer with large bandwidth needs to be carefully chosen. Due to ocular attenuation of high frequency ultrasonic waves, it's suggested that high sensitivity in PAOM is more achievable with relative narrow bandwidth [@bib0580]. Therefore, the tradeoff between axial resolution and detection sensitivity needs a balance. For imaging speed, it can still be improved, depending on laser repetition rate, until it is limited by the ultrasound propagation time from the posterior eye. High imaging speed will reduce the influence of eyeball motion on image quality.

### 4.1.4. Exogenous contrast agents for photoacoustic ophthalmic imaging {#sec0070}

Exogenous contrast agents are widely used in PA imaging to improve photoacoustic imaging quality [@bib0190], [@bib0585], and to extend the imaging scopes to molecular and genetic imaging [@bib0590]. Despite not being used in ocular PA imaging yet, some of the common adopted ophthalmic contrast agents were already tested on other anatomic sites and achieved enhanced results. These exogenous agents will have great potential to improve/extend PA ophthalmic applications. We summarize the common used ophthalmic contrast agents in [Table 3](#tbl0015){ref-type="table"}.

4.2. Photoacoustic imaging of animal eyes {#sec0075}
-----------------------------------------

Before clinical adaptation, ocular PA imaging requires numerous animal studies to verify the longitudinal performance stability of ocular PA measurements. Also, better understanding of early disease activity is important to apply PA imaging for ocular diseases detection. For example, knowing how early can PA detect retinal sO~2~ changes in DR would be helpful in determining when to begin screening diabetic patients with the technology. Lastly, visual stimuli can cause neurovascular coupling in the retina, and have been reported to change retinal vessel diameter, blood flow, and retinal sO~2~ [@bib0595], [@bib0600], [@bib0605]. The reported visual stimulus had a flicker frequency between 10 Hz and 60 Hz, with a stimulation time greater than 10 s [@bib0610]. These stimuli are vastly different from the visible light that is used for illumination in PAOM, which has a repeat frequency of up to several kilohertz. Still, studies examining how visible light illumination influences PAOM accuracy are needed.

5. Summary {#sec0080}
==========

This mini review briefly introduced ocular physiology, described prevalent ocular diseases that cause blindness, and summarized evidence of aberrant retinal sO~2~ and RPE melanin concentration in these blinding diseases. We also described recent efforts to measure retinal sO~2~ and RPE melanin concentration and discussed how PA imaging allows for the precise quantification of these parameters. We summarized recent developments in PA imaging that have improved both anterior and posterior segment imaging, and discussed potential areas of research that will facilitate adopting ocular PA imaging in the clinical setting.
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![(a) Schematic of normal ocular anatomy, I is anterior chamber, II is retinal pigment epithelium, III is vitreous. (b) Illustration of the retinal and choroidal vascular systems that nourish the retina in the posterior segment. RPE: retinal pigment epithelium.](gr1){#fig0005}

![Optical absorption spectra of blood components and melanin. HbR: deoxy-hemoglobin; HbO~2~: oxy-hemoglobin; MbO~2~: oxy-myoglobin; MbR: reduced myoglobin.](gr2){#fig0010}

![(a) Schematic of a mechanical-scanning OR-PAM. (b) An in-vivo OR-PAM image of the iris microvasculature in an albino mouse. A false-colored map of the iris vasculature in the rectangular outlined area shows vessel sO~2~. (c) A PA image showing iris melanin (red arrows) in an ex-vivo pig eye. ND: neutral density, AO: acoustic-optical, RIA: radial iris artery, MIC: major iris circle, RCB: recurrent choroidal branch, CP: ciliary process.](gr3){#fig0015}

![OR-PAM imaging of mouse corneal vasculature in vivo. (a) Full-volume projection PAM image. (b) Cross-sectional PAM B-scan image taken along the dashed line in panel (a). The iris melanin (lower arrow) and corneal vessels (upper arrows) are clearly visible. (c) Corneal vasculature projection after segmentation of the corneal vasculature and iris melanin. Scale bar: 200 μm.](gr4){#fig0020}

![(a) An optical scanning PAOM combined with OCT. (b) Illustration of ultrasonic transducer position and how the optical illumination beam enters the eye and focuses on the retina. SLD: superluminescent diode, OCT: optical coherence tomography, PC: polarization controller, CCD: charge coupled device, Pd: photodiode, UT ultrasonic transducer, FOV: field of view.](gr5){#fig0025}

![(a) PAOM imaging of retinal vasculature in an albino mouse. (b) PAOM imaging of choroidal vasculature in an albino mouse; 1 major choroidal vessels, 2 small choroidal vessels. (c) PAOM imaging of retinal pigment epithelium melanin (red arrows) and the retinal vasculature in a pigmented rat. Scale bar: 100 μm. [Fig. 6](#fig0030){ref-type="fig"} (a) and (b).](gr6){#fig0030}

![Retinal oxygen metabolic rate was measured using integrated PAOM and OCT. (a) Image of the retinal and choroidal vasculature obtained with PAOM at 570 nm. (b) Calculated oxygen saturation (sO~2~) values in the major retinal vessels. (c) Cross-sectional OCT B-scan image obtained along the white circle in (a). (d) OCT phase shift B-scan image taken along the white circle in (a). (e) Measured flow rate in the retinal arterial and venous systems. Scale bars: 200 μm.](gr7){#fig0035}

###### 

Summary of ophthalmic imaging devices.

Table 1

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Technology                                           Technique requirements                        Applications                                                                    Advantages                                                                   Concerns
  ---------------------------------------------------- --------------------------------------------- ------------------------------------------------------------------------------- ---------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------
  OCT [@bib0115], [@bib0615], [@bib0620], [@bib0625]   Broadband illumination,\                      Intra-retinal layer structures, angiography, blood flow, sO~2~, birefringence   High depth and lateral resolution, non-contact sensing of multi-parameters   Limited field of view in angiography, artifacts in flow and birefringence imaging, human retinal sO~2~ is not reported yet.
                                                       interferometer based sensing,\                                                                                                                                                                             
                                                       confocal detection,\                                                                                                                                                                                       
                                                       optical scanning                                                                                                                                                                                           

  cSLO [@bib0630], [@bib0635]                          Narrowband/single wavelength illumination,\   Retinal fundus structures, fluorescein angiography, sO~2~, auto-fluorescence    High lateral resolution,\                                                    Poor depth resolution\
                                                       confocal detection,\                                                                                                          fast imaging                                                                 , measurement of sO~2~ is influenced by light scattering, angiography requires contrast agents
                                                       optical scanning                                                                                                                                                                                           

  Fundus\                                              Flood illumination                            Retinal fundus structures, fluorescein angiography,\                            Non optical scanning,\                                                       Non-depth resolution\
  Photography [@bib0090], [@bib0640], [@bib0645]                                                     sO~2~, auto-fluorescence                                                        fast imaging,                                                                , measurement of sO~2~ is influenced by light scattering,angiography requires contrast agents, speckle noise, aberrations

  HSI [@bib0650], [@bib0655]                           Broadband illumination,\                      Retinal fundus structures,\                                                     Non optical scanning\                                                        Slow imaging, non-depth resolution, measurement of sO~2~ and pigment are influenced by light scattering
                                                       Flood illumination                            sO~2~, macular pigment                                                          Spectroscopic analysis                                                       

  PAOM [@bib0325], [@bib0355]                          Pulse laser excitation,\                      Angiography, sO~2~ and pigment imaging                                          Moderate depth resolution, pure optical absorption sensing                   Image only optical absorption, require "contact" detection
                                                       acoustic signals detection,\                                                                                                                                                                               
                                                       optical scanning                                                                                                                                                                                           
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Summary of reported photoacoustic imaging of eye.

Table 2

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reported system                      Scanning pattern          Reported imaging speed and imaging size   Reported resolution   Reported Laser illumination          Reported Laser safety evaluation   Applications
  ------------------------------------ ------------------------- ----------------------------------------- --------------------- ------------------------------------ ---------------------------------- -------------------------------------
  Zerda et al. [@bib0315]\             Wide filed illumination   90 min for 12 mm × 8 mm                   Axial: 50/83 μm\      Wavelength: 740 nm\                  Safe (Based on ANSI 2000)          Both anterior and posterior segment
  (*Both in vivo and ex vivo study*)                                                                       Lateral: 200/240 μm   Pulse energy density: 0.5 mJ/cm^2^                                      

  Hu et al. [@bib0320]\                Mechanical scanning       120 min for 2 mm × 2 mm                   Axial: 15 μm\         Wavelength: 570/578 nm\              Safe (Based on ANSI 2007)          Anterior segment
  (*in vivo study*)                                                                                        Lateral: 5 μm         Pulse energy: 40 nJ                                                     

  Liu et al. [@bib0365]\               Mechanical scanning       20 min for 3\                             Axial: 50 μm\         Wavelength: 532 nm\                  Safe (Based on ANSI 2007)          Anterior segment
  (*in vivo study*)                                              mm × 3 mm                                 Lateral: 2.76 μm      Pulse energy: 80 nJ                                                     

  Silverman et al. [@bib0360]\         Mechanical scanning       Not mentioned                             Axial: 37 μm\         Wavelength: 532/1064 nm\             Not Safe (Based on ANSI 2007)      Both anterior and posterior segment
  (*ex vivo study*)                                                                                        Lateral: 20 μm        Pulse energy: 1 μJ                                                      

  Wu et al. [@bib0370]\                Mechanical scanning       6.5 min for 2 mm × 2 mm                   Axial: 45 μm\         Wavelength: 532 nm\                  Not Safe (Based on ANSI 2007)      Both anterior and posterior segment
  (*In vivo study*)                                                                                        Lateral: 5 μm         Pulse energy: 500 nJ                                                    

  Jiao et al. [@bib0325]\              Optical scanning          2.7 s for 2 mm × 2 mm                     Axial: 23 μm\         Wavelength: 532 nm\                  Safe (Based on ANSI 2007)          Posterior segment
  (*In vivo study*)                                                                                        Lateral: 20 μm        Pulse energy: 40 nJ                                                     

  Song et al. [@bib0345]\              Optical scanning          2.7 s for 2 mm × 2 mm                     Axial: 23 μm\         Wavelength: 532 nm\                  Safe (Based on ANSI 2007)          Posterior segment
  (*In vivo study*)                                                                                        Lateral: 20 μm        Pulse energy: 40 nJ                                                     

  Song et al. [@bib0355]\              Optical scanning          2.7 s for 2 mm × 2 mm                     Axial: 23 μm\         Wavelength: 570/578/588 nm\          Safe (Based on ANSI 2007)          Posterior segment
  (*In vivo study*)                                                                                        Lateral: 20 μm        Pulse energy: 40 nJ                                                     

  Liu et al. [@bib0385]\               Optical scanning          2.7 s for 2 mm × 2 mm                     Axial: 23 μm\         Wavelength: 532 nm\                  Safe (Based on ANSI 2007)          Posterior segment
  (*In vivo study*)                                                                                        Lateral: 20 μm        Pulse energy: 60 nJ                                                     
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Summary of common ophthalmic contrast agents for photoacoustic imaging.

Table 3

  Contrast agents                                  Benefits and Applications                                                                                                        Concerns
  ------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------
  Evans blue [@bib0660]                            Complete and continuous microvascular network mapping                                                                            Photobleaching of Evans blue
  Indocyanine green (ICG) [@bib0665], [@bib0670]   Near-infrared photoacoustic imaging, high penetration depth                                                                      Rapid circulation and clearance from bloodstream
  Nanoparticles [@bib0675]                         Near-infrared photoacoustic imaging, high penetration depth; biomarkers for molecular imaging; relative slow tissue clearance.   Safety issue
